← Open Payments lookup

KEBBA LOBBA: Open Payments

NPI 1811656887 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$866 in 28 payments from 10 companies in 2025. Trend: 2023 $232 · 2024 $930 · 2025 $866

Food & beverage: $866
CompanyPaymentsAmount
ABBVIE INC.9$160
Janssen Pharmaceuticals, Inc1$150
Alkermes, Inc.1$113
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$87
Teva Pharmaceuticals USA, Inc.1$84
Otsuka America Pharmaceutical, Inc.4$79
Axsome Therapeutics, Inc.3$74
E.R. Squibb & Sons, L.L.C.3$73
Lundbeck LLC1$25
Luye Pharma (USA) Ltd.1$20

Products named: VRAYLAR, INVEGA, LYBALVI, CAPLYTA, AUSTEDO XR, Auvelity, COBENFY, ABILIFY ASIMTUFII.

Industry payments across TX — which companies pay providers there.